Microsoft CorporationCausaly's agentic scientific research is integrated into Microsoft Copilot, adding a vertical scientific workflow layer to the product.

Causaly announced an expansion of its collaboration with Microsoft that makes its agentic scientific research available directly inside Microsoft Copilot. Enterprise life sciences R&D teams can now access Causaly within their existing Microsoft 365 workflows, including the Copilot app and Microsoft Teams, where users invoke the agent from its menu or by mentioning Causaly in a conversation. The integration adds a vertical scientific workflow layer to Copilot, orchestrating end-to-end research that surfaces prior science, reasons over biological mechanisms, and synthesizes evidence into cited answers, with every response carrying traceable references back to peer-reviewed literature, biomedical databases, and Causaly's proprietary Bio Graph and Pipeline Graph knowledge graphs. The move builds on the collaboration the two companies announced at Microsoft Build 2026 in June, which paired Causaly's scientific interpretation with Microsoft Discovery's enterprise scientific platform. Causaly co-founder and CEO Yiannis Kiachopoulos said the extension puts governed, provenance-first scientific reasoning inside the same interface used across research, development, medical, and commercial functions in biopharma, while Microsoft 365 Copilot principal product manager Chantrelle Neilsen called the integration a strong example of specialized enterprise agents grounded in evidence and available where the work happens. Causaly is available on the Microsoft Marketplace.
Microsoft CorporationCausaly's agentic scientific research is integrated into Microsoft Copilot, adding a vertical scientific workflow layer to the product.
Expanded Microsoft collaboration makes Causaly's agentic scientific research available inside Copilot and Microsoft 365 workflows, broadening its enterprise reach.